← Back to Search

Carotenoids

Lutein, zeaxanthin and mesozeaxanthin for Glaucoma

Phase 1 & 2
Waitlist Available
Led By Felipe A Medeiros, MD, PhD
Research Sponsored by Felipe Medeiros, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 6 months
Awards & highlights

Study Summary

This study is evaluating whether a specific pigment in the eye may be related to visual performance in glaucoma patients.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Contrast Sensitivity
Change in the Macular Pigment Optical Density
Secondary outcome measures
Change in Vision in Glare as Measured by Percentage of Contrast
Change in Visual Field Assessment
Change in the Point-spread Function
+2 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Lutein, zeaxanthin and mesozeaxanthinActive Control1 Intervention
Patients will be asked to consume 1 pill daily with a meal, for six months. The pills will contain 22 mg total of the carotenoids lutein (10 mg), zeaxanthin (2 mg), and mesozeaxanthin (10 mg).
Group II: PlaceboPlacebo Group1 Intervention
Patients will be asked to consume 1 pill daily with a meal, for six months. The pills will contain only sunflower oil (placebo).

Find a Location

Who is running the clinical trial?

Industrial Orgánica S.A. de C.V.UNKNOWN
Felipe Medeiros, MDLead Sponsor
Heidelberg Engineering GmbHIndustry Sponsor
15 Previous Clinical Trials
1,996 Total Patients Enrolled
5 Trials studying Glaucoma
841 Patients Enrolled for Glaucoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Macular Pigment and Visual Performance in Glaucoma Patients
Felipe Medeiros, MD 2019. "Macular Pigment and Visual Performance in Glaucoma Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03959592.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top